No Data
No Data
Express News | HC Wainwright & Co. Reiterates Buy on Regulus Therapeutics, Maintains $10 Price Target
H.C. Wainwright Maintains Regulus Therapeutics(RGLS.US) With Buy Rating, Maintains Target Price $10
Buy Rating Affirmed for Regulus Therapeutics Amid Positive RGLS8429 Study Results
Regulus Therapeutics Announces Participation at Two Healthcare Investment Conferences
Express News | Canaccord Genuity Maintains Buy on Regulus Therapeutics, Raises Price Target to $28
Ball To Rally More Than 23%? Here Are 10 Top Analyst Forecasts For Tuesday
No Data
Newbie93 OP : it even penetrate through the daily 200ema
Newbie93 OP : dead stock